Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus

Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus

(2014) J-Y Choe et al.   LUPUS

Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis

(2013) B Abujam et al.   LUPUS

Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding

(2013) Alfred Lammens et al.   PLoS One

Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?

(2013) Daniel Bertin et al.   Frontiers in Immunology

The Role of Cytokines in the Pathogenesis and Treatment of Systemic Lupus Erythematosus

(2011) Laurie S. Davis et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

CXCR3, Inflammation, and Autoimmune Diseases

(2009) Stéphanie Lacotte et al.   Annals of the New York Academy of Sciences

The search for lupus biomarkers

(2009) Chau-Ching Liu et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study

(2009) Noa Schwartz et al.   ARTHRITIS RESEARCH & THERAPY